Collum Femoris-Preserving Hip Stem: Clinical and Radiographical Results from a Medium-Term, Multi-Centric Study in a Latin American Population

Abstract

Background: There is a lack of information related to the medium-term results of short stem prosthesis in the Latin-American population. This study represents the longest follow-up results of the CFP prosthesis in the Latin-American population. Methods: Two-hundred fifty-five patients treated with anatomic neck preserving from June 2013 to June 2020 were enrolled in the current study. The mean follow-up was 81 (60-96) months. All the subjects were available for the follow-up examination at a minimum of 5 years after surgery. Clinical results were assessed using Oxford Hip Score (OHS). Radiologic assessment was performed at each follow-up. Results: Follow-up was 81 (60-96) months. Two-hundred fifty-five patients were contacted. The patients with hip dysplasia were operated with the CFP stem in 10.2% of all cases; with regards to the Dorr classification of the proximal femur, type 1: 9.8%; type 2: 88.6% and type 3: 1.6%. The overall prosthesis survival was 96.1%. The functional results were OHS pre: 9.1 (3-35), post: 44.4 (27-48). Conclusion: The surgeries with CFP stem have excellent clinical results. The main indication of this short stem is primary hip osteoarthritis; nevertheless, we have some experience in dysplastic hips with good clinical results and survivorship. The results are comparable in terms of survivorship when this stem is implanted in Dorr 1, 2 and 3; however, we had a limitation, the sample was not comparable in the three groups. The overall survivorship, the functional scales and the radiographical results in the Latin-American population are comparable with literature reported around the world. Level of Evidence: Level III